Amalgamated Bank lifted its holdings in shares of athenahealth, Inc (NASDAQ:ATHN) by 5.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 7,892 shares of the health services provider’s stock after purchasing an additional 427 shares during the period. Amalgamated Bank’s holdings in athenahealth were worth $1,050,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the company. The Manufacturers Life Insurance Company grew its holdings in shares of athenahealth by 7.7% during the second quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock worth $166,000 after purchasing an additional 84 shares during the last quarter. Stifel Financial Corp boosted its holdings in athenahealth by 7.1% in the third quarter. Stifel Financial Corp now owns 8,828 shares of the health services provider’s stock valued at $1,094,000 after acquiring an additional 582 shares during the last quarter. Fox Run Management L.L.C. boosted its holdings in athenahealth by 19.2% in the fourth quarter. Fox Run Management L.L.C. now owns 4,412 shares of the health services provider’s stock valued at $587,000 after acquiring an additional 712 shares during the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in athenahealth by 2.4% in the third quarter. Oppenheimer Asset Management Inc. now owns 31,974 shares of the health services provider’s stock valued at $3,977,000 after acquiring an additional 737 shares during the last quarter. Finally, Swiss National Bank boosted its holdings in athenahealth by 1.2% in the third quarter. Swiss National Bank now owns 66,630 shares of the health services provider’s stock valued at $8,286,000 after acquiring an additional 800 shares during the last quarter.

How to Become a New Pot Stock Millionaire

Several research firms recently issued reports on ATHN. Bank of America began coverage on athenahealth in a report on Tuesday, February 27th. They issued a “neutral” rating and a $147.00 price target on the stock. BidaskClub upgraded athenahealth from a “strong sell” rating to a “sell” rating in a report on Saturday, February 17th. Piper Jaffray Companies reiterated a “buy” rating and issued a $160.00 price target on shares of athenahealth in a report on Friday, February 16th. Royal Bank of Canada set a $141.00 price target on athenahealth and gave the company a “hold” rating in a report on Thursday, February 15th. Finally, SunTrust Banks raised their price target on athenahealth to $180.00 and gave the company a “buy” rating in a report on Monday, February 5th. Three analysts have rated the stock with a sell rating, seventeen have assigned a hold rating and seven have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $144.35.

athenahealth, Inc (NASDAQ:ATHN) opened at $145.62 on Thursday. athenahealth, Inc has a one year low of $95.01 and a one year high of $158.66. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $5,840.00, a PE ratio of 117.44, a price-to-earnings-growth ratio of 2.58 and a beta of 1.17.

athenahealth (NASDAQ:ATHN) last released its earnings results on Thursday, February 1st. The health services provider reported $1.11 earnings per share for the quarter, beating the consensus estimate of $0.63 by $0.48. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The firm had revenue of $329.20 million for the quarter, compared to analyst estimates of $319.64 million. During the same quarter in the prior year, the firm posted $0.62 earnings per share. The company’s quarterly revenue was up 14.2% on a year-over-year basis. equities research analysts expect that athenahealth, Inc will post 2.69 EPS for the current fiscal year.

In other news, CEO Jonathan Bush sold 25,000 shares of the firm’s stock in a transaction dated Monday, February 5th. The stock was sold at an average price of $145.00, for a total transaction of $3,625,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CMO Timothy John O’brien sold 3,064 shares of the firm’s stock in a transaction dated Friday, March 2nd. The stock was sold at an average price of $137.27, for a total value of $420,595.28. Following the sale, the chief marketing officer now directly owns 11,320 shares in the company, valued at approximately $1,553,896.40. The disclosure for this sale can be found here. Insiders sold 108,705 shares of company stock worth $14,891,199 in the last three months. Insiders own 3.20% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another site, it was stolen and reposted in violation of United States & international copyright & trademark law. The legal version of this news story can be viewed at https://www.dailypolitical.com/2018/03/15/athenahealth-inc-athn-shares-bought-by-amalgamated-bank.html.

athenahealth Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc (NASDAQ:ATHN).

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.